Rion’s PEPTM (Purified Exosome ProductTM) is an allogeneic, off-the-shelf regenerative medicine platform that has therapeutic utility in a wide array of clinical applications where tissue regeneration is needed. Rion has established scientific collaborations to study PEP’s regenerative potential for a variety of diseases. The company is currently evaluating PEP in preclinical and clinical studies for wound healing, cardiovascular disease, and pelvic floor disorders. In parallel with our in-house programs, Rion is exploring partnerships to bring new applications forward into preclinical and clinical development.
In parallel with our in-house programs, Rion is interested in partnerships to bring new applications forward into pre-clinical and clinical development.
For partnering inquiries, please contact us at email@example.com.
Rion is a member of the Mayo Clinic Innovation Exchange and: